Aurangabad Plant operation started in 1979. This is the first plant of Lupin with various dosage forms like Tablets, Capsules and Liquids.

Year of foundation : 1979

Address : A/28/1, MIDC Industrial Area, Chikalthana Aurangabad 431 210

No. of Plants : 1

Nature of business : Manufacturing of tablets, capsules and liquids

Size of the facility : 60000 sqm

Employees : 250

Approvals :WHO / US FDA / MCC / TGA

The Company is an ISO 14001 and OSHAS 18001 Company.

It has well integrated environment system to treat the effluent water whereby the characteristics are below the norms of Gujarat Pollution Control Board.

Manufacturing practices are in compliance to cGMP norms.

Year of foundation : 1982

Address : 124, GIDC Estate, Ankleshwar 393002 Gujarat

No. of Plants : 9

Nature of business : Manufacturing Intermediates and Bulk drugs

Size of the facility : 40 acres

Employees : 921

Approvals : FDA / CCA / WHO GMP / KFDA / ISO-14001 / OSHAS-18001

This facility is engaged in the manufacturing of APIs as well as dosage forms which produces Sterile and Non-Sterile pharmaceuticalproducts and mainly caters to the US and Europe markets.

Year of foundation : 1986

Address : 198-202, New Industrial Area No. 2, Mandideep, Dist. Raisen 462046, M.P

No. of Plants : 9

Nature of business : Manufacturing of APIs (Cephalosporins & Cardiovascular) and Formulations

Size of the facility : 58 Acres

Employees : 1171

Approvals : US FDA / UK MHRA / AFSSAPS-France / TGA-Australia / MEDSAFE-New Zealand / WHO

The manufacturing facility for APIs has been started in 1992 and has state-of-an-art fermentation facility and synthetic API manufacturing Multi product plants. The Facility has been inspected by US FDA, MHRA and WHO. It has captive power plant (with 100% back up).

Year of foundation : 1992

Address : T-142, MIDC Tarapur, Boisar (West), Dist. Thane, Maharashtra 401506

No. of Plants : 14 Manufacturing Plant and 5 Solvent Recovery blocks

Nature of business : Manufacturing of "Active Pharma Ingredient" (Fermentation based and synthetic)

Size of the facility : 199025 Sqm (build up area is 80775 sqm)

Employees : 812

Approvals : US FDA / MHRA / WHO

Goa plant foundation stone Project start up was done in August 2003 and it was built up in record time of only 6 months to start operations in Feb 2004 Pilot scale operations started in March / April 2004 with initiation of Exhibit batches of Lisinopril tablets for US market and EU market.

The plant started with a Manpower total strength of only vbn30 people in 2004. First US & EU Regulatory filing for Lisinopril tablets from Goa was done which made Goa sail through its first USFDA Pre Approval inspection in June 2005 and MHRA inspection in Nov 2005.

Goa plant has been subjected to lay out extension in five phases in last six years to manufacture and deliver oral dosage forms with a capacity of more than 8 Billion units / Annum.

Till date Goa plant has executed more than 200 Exhibit Products for US EU and AU markets . It has been inspected by USFDA four times and MHRA thrice. It is also inspected by WHO Indian agency thrice.

Commercial supplies to US & EU market were initiated with product Lisinopril tablets in Nov 2005 & Aug 2007 respectively. As on date the plant supplies more than 60 products to regulated markets of US, EU & AU.

Goa plant has filed as on date 90 ANDA's in US market and more than 50 filings in EU & AU market.

Milestones

• Plant Foundation : Aug 2003

• Plant Operations Start up : Feb 2004

• Exhibit batches start up : April 2004

• Commercial batches start up : Nov 2005

Year of foundation : 2003

Address : B-15, Phase 1A, Verna Industrial Area, Verna Salcette-Goa 403722

No. of Plants : 1

Nature of business : Formulations – Solid Oral Facility

Size of the facility : 22618 sqm

Employees : 619

Approvals : US FDA / MHRA / WHO

The Plant is located at about 17 Kms from Jammu city. Jammu is also known as " City of Temples " and Winter Capital of J&K. The Temperature in Winter goes to Min- 1-3 Deg C and 44-45 Deg C during Summers. Dogri, Hindi, Punjabi, Kashmiri, Urdu are the common languages spoken in the area. Jammu is well connected by train, road and air. Delhi is 600 kms and Srinager ( Summer Capital of J&K) 300 kms from Jammu.

Year of foundation : March 2006

Address : EPIP Kartholi, SIDCO, Bari Brahmana Dist. Samba, Jammu & Kashmir 181133

No. of Plants : 1

Nature of business : Formulations

Size of the facility : 59 Kanals (7.36 acres)

Employees : 172

Approvals : WHO Geneva

This site has state of art in manufacturing wide range of products in various categories like CRAMS, Pharmaceuticals Intermediates and APIs for international as well as domestic sale. It has well equipped and multi range facilities to deliver the products in the range of developmental quantity to commercial scale. Facilities are well designed and qualified to meet the cGMP requirement and having a competent workforce for the need. It is also backed up with onsite R&D center. Site is emerging as one of the facility for manufacturing APIs for advance markets.

Year of foundation : 2007 (Acquired from Rubamin Pharmaceuticals).

Address : Block 21, Village Dabhasa, Ta-Padra Vadodara 391440

No. of Plants : 6

Nature of business : Intermediates and API Manufacturing

Size of the facility : 30 acres

Employees : 285

Approvals : ISO-9001 / ISO-14001 / OHSAS-18001 / WHO cGMP

Lupin's latest formulation facility, having satisfactory USFDA and UK-MHRA compliance. This plant is located in special economic zone.

Dedicated facilities for manufacturing of API for Contraceptives, Oral Contraceptive, Oral Solid Dosage Forms, Ophthalmic Solutions, Dermal Dosage Forms.

Manufacturing capacity - 10 Billion tablets.

Year of foundation : 2008

Address : Plot No. 2, Special Economic Zone Phase – II, Misc. Zone Apparel Park, Dist.- Dhar, Pithampur,
MP- 454 775, INDIA

No. of Plants : 5

Nature of business : Manufacturing of Formulations and Active Pharmaceutical Ingredients (APIs)

Size of the facility : 107965 sqm

Employees : 679

Approvals : US FDA / MHRA / TGA